T 1680/17 (Fulvestrant/ASTRAZENECA) of 24.01.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T168017.20190124
- Date of decision
- 24 January 2019
- Case number
- T 1680/17
- Petition for review of
- -
- Application number
- 10180667.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Fulvestrant formulation
- Applicant name
- AstraZeneca AB
- Opponent name
- Hexal AG
Actavis Group PTC ehf
Fresenius Kabi Deutschland GmbH
Intas Pharmaceuticals Ltd.
Teva Pharmaceutical Industries Ltd. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 123(2)European Patent Convention Art 54(2)European Patent Convention Art 56European Patent Convention Art 76(1)
- Keywords
- Inventive step - (yes)
Inventive step - reasonable expectation of success (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- G 0002/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The oppositions are rejected.